I MOVE!+UP: Piloting an Integrated Weight Management Program for Veterans With PTSD

Sponsor
VA Puget Sound Health Care System (U.S. Fed)
Overall Status
Recruiting
CT.gov ID
NCT05755100
Collaborator
(none)
30
1
1
19.6
1.5

Study Details

Study Description

Brief Summary

This study seeks to test I MOVE!+UP, which integrates individual evidence-based psychotherapy for PTSD with behavioral weight management among Veterans with a Body Mass Index of at least 30 and meeting criteria for current PTSD. Participants will continue receiving routine primary care and psychiatric care management as indicated, in coordination with the I MOVE!+UP therapist. This study is being conducted to see whether I MOVE!+UP holds promise as a treatment for commonly co-occurring PTSD and high Body Mass Index. Participation will involve attending up to 16 psychotherapy visits that last approximately 1-2 hours over 6 months and attending 2 study assessment visits that last approximately 1-2 hours at enrollment and 6 months. Active participation will take up to approximately 6 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: I MOVE!+UP
N/A

Detailed Description

Post-traumatic stress disorder (PTSD), prevalent among Veterans, puts Veterans at increased risk for obesity and related conditions. Veterans with PTSD lose less weight in VA's MOVE! weight management program, due to PTSD symptoms that interfere with activity and healthy diet. In addition, many Veterans who receive evidence-based PTSD treatment remain symptomatic. A behavioral weight loss program that augments standard PTSD care and targets PTSD-related weight loss barriers called MOVE!+UP was piloted and iteratively refined among 44 overweight Veterans with PTSD, and is currently being tested in an RCT. However, not all Veterans will participate in group-based treatment and prior work on integrated tobacco cessation with individual psychotherapy was quite impactful, and was particularly well-suited for coordinating augmentative medication management using shared decision-making. As such, we propose to conduct an uncontrolled pilot of an intervention called I MOVE!+UP. It will integrate MOVE!+UP into individual evidence-based psychotherapy (i.e.., Cognitive Processing Therapy) for PTSD for up to 6 months, augmented with evidence-based psychiatric and weight management medication management coordination. If I MOVE!+UP is acceptable, feasible, and proof-of-concept outcomes demonstrate potential benefit to weight and PTSD outcomes, we will apply for large-scale funding to test it in an RCT. I MOVE!+UP integrated behavioral intervention will be led by a psychotherapist (social worker, psychologist, or trainee in those disciplines). Because this care will be delivered within the context of routine mental health care, patients will be offered the opportunity for individualized pharmacotherapy for weight loss and psychiatric symptom management as part of their care plan.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Uncontrolled pilot trial.Uncontrolled pilot trial.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
I MOVE!+UP: Piloting an Integrated Weight Management Program for Veterans With PTSD
Actual Study Start Date :
Jan 12, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Pilot study of I MOVE!+UP among Veterans with PTSD and BMI of 30 or greater.

Single arm pilot trial.

Behavioral: I MOVE!+UP
An individual psychotherapy that integrates behavioral weight management with evidence-based psychotherapy for PTSD (Cognitive Processing Therapy) for up to 6 months, augmented with evidence-based psychiatric and weight management medication management.

Outcome Measures

Primary Outcome Measures

  1. Weight [change from baseline to 6 months]

    in person weight taken during research visit

  2. PTSD symptoms [change from baseline to 6 months]

    PCL-5 (self-reported)

Secondary Outcome Measures

  1. Depression symptoms [change from baseline to 6 months]

    PhQ-8 (self-reported)

  2. Insomnia severity [change from baseline to 6 months]

    Insomnia severity index (self-reported)

  3. Diet quality [change from baseline to 6 months]

    Starting the Conversation (self-reported)

  4. Social support for physical activity and healthy eating [change from baseline to 6 months]

    Modified based on Sallis et al measure (self-reported)

  5. Internalized weight bias [change from baseline to 6 months]

    Internalized weight bias measure (self-reported)

  6. Health-related quality of life [change from baseline to 6 months]

    Sf-12 (self-reported)

  7. Waist circumference [change from baseline to 6 months]

    In person, taken during research visit

  8. Blood pressure (systolic) [change from baseline to 6 months]

    In person, taken during research visit

  9. Blood pressure (diastolic) [change from baseline to 6 months]

    In person, taken during research visit

  10. Total cholesterol [change from baseline to 6 months]

    In person, bloodwork taken during research visit

  11. LDL cholesterol [change from baseline to 6 months]

    In person, bloodwork taken during research visit

  12. HDL cholesterol [change from baseline to 6 months]

    In person, bloodwork taken during research visit

  13. Triglycerides [change from baseline to 6 months]

    In person, bloodwork taken during research visit

  14. HbA1C [change from baseline to 6 months]

    In person, bloodwork taken during research visit

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
    • PTSD Diagnosis: standard criteria for PTSD Checklist for DSM-5 (PCL-5): lifetime.
    • Experience of trauma, a score of ≥33, and meets criteria for the symptom domains.
    • Body Mass Index (BMI) of ≥ 30 kg/m2.
    • Willing to participate in all intervention and assessment activities
Exclusion Criteria:
    • Not fluent in English, severe hearing loss, no phone access.
    • Current MOVE! participation (at least 2 sessions in the past 3 months.)
    • Current PTSD psychotherapy participation (at least 2 PE or CPT sessions in the past 3 months.)
    • Past year bariatric surgery or planning to have bariatric surgery in next 6 months.
    • Current pregnancy.
    • Based on clinical judgment, would be unable to participate because of a) acutely exacerbated substance use, mental health, or chronic medical conditions or b) moderate to severe chronic, progressive neurologic conditions such as Dementia.

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Puget Sound Health Care System Seattle Washington United States 98108

Sponsors and Collaborators

  • VA Puget Sound Health Care System

Investigators

  • Principal Investigator: Katherine L Hoerster, PhD, MPH, VA Puget Sound Health Care System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Katherine Hoerster, Principal Investigator, VA Puget Sound Health Care System
ClinicalTrials.gov Identifier:
NCT05755100
Other Study ID Numbers:
  • 0009
First Posted:
Mar 6, 2023
Last Update Posted:
Mar 6, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2023